-Advertisement-
-Advertisement-
Oculoplastics
Teprotumumab significantly reduces extraocular muscle cross-sectional area in TED
After treatment with teprotumumab in patients with thyroid eye disease (TED), extraocular muscle (EOM) cross-sectional areas (CSA) is significantly reduced, according to a study. In this retrospective study, pre- and post-teprotumumab treatment CT imaging of 48 orbits of 24 patients with thyroid eye disease were evaluated by 2 radiographic reviewers...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Quizzes
-Advertisement-
-Advertisement-
Contact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved